Abstract:Objective To Observe dynamically the level of CD_4~+ CD_(25)~+ Tregs in the peripheral blood in patients with liver failure receiving artificial liver support system and/or medical treatment and investigate the relationship between the level of CD_4~+ CD_(25)~+ Tregs and curative effect and prognosis.Methods Sixty-three patients with liver failure were divided into 2 groups according to the treatment protocol:medical treatment combined with artificial liver support system(combined group)(29 cases)and medical treatment only group (medical group)(34 cases).According to indicators such as liver function and clinical symptoms etc,there were 17 effective cases and 12 ineffective cases in the combined group while 11 effective cases and 23 ineffective cases in the medical group.23 healthy donors were used as normal control group.The level of CD_4~+ CD_(25)~+ Treg in the peripheral blood was measured by flow cytometry dynamically and the relationship between the level of CD_4~+ CD_(25)~+ Treg and curative effect was analyzed accordingly.Results The Treg level was(2.46±0.56)% in the normal control group.For those effective groups,the Treg level before treatment was lower compared to normal control group,it was(1.92±0.78)% and(2.10±0.56)% in combined group and medical group respectively.There was no significant difference between these two groups (P0.05)although it was statistically significant when both compared to the normal control group(P 0.05);After treatment,the Treg level in the effective groups was(2.62±0.67)%(combined group)and (2.89±0.72)%(medical group)respectively.There was significant difference between these two groups (P0.05)while no statistical significant was found when compared to the normal control group(P 0.05);Both effective groups showed significant difference before and after the treatment(P0.05);As to the ineffective groups,the Treg level was higher before treatment compared to the normal control.It was (4.64±1.31)%(combined group)and(4.87±2.86)%(medical group)respectively.There was no significant difference between these two groups(P0.05)while it was statistical significant when compared to the normal control group(P0.05);After treatment the Treg level in the ineffective groups was(5.44± 2.13)%(combined group)and(5.91±2.78)%(medical group)respectively.There was no significant difference between these two groups(P0.05)although it was statistically significant compared to the normal control group(P0.05).There was significant difference before and after the treatment in both ineffective groups(P0.05).The change of Treg level appeared to show low-high-low peaked curve in the effective groups and it recovered to the normal level soon in the combined group compared to the medical treatment group.In the ineffective treatment groups,the change of Treg level appeared to be high-low-high notched curve.Conclusion The level of CD_4~+ CD_(25)~+ Treg was correlated with the curative effect and it may be used as a potential indicator for curative effect and prognosis in patients with liver failure.

The significance of hepatic regulatory T cells in patients with autoimmune hepatitis

[Cd4+cd25+high Regulatory T Cells in Patients with Autoimmune Hepatitis].

The Imbalance Between Foxp3(+)Tregs and Th1/Th17/Th22 Cells in Patients with Newly Diagnosed Autoimmune Hepatitis

The role of liver-targeted CD4+ CD25+ Foxp3+ regulatory T cells in the patients with chronic hepatitis B

Phenotypes and clinical significance of circulating CD4 + CD25 + regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF)

The Clinical Significance of Hepatic CD69 + CD103 + CD8 + Resident‐Memory T Cells in Autoimmune Hepatitis

[Study of the Correlation Between Elevated Level of T-bet Expression and Liver Damage in Peripheral Plasma Cells of Patients with Autoimmune Hepatitis].

Th17/Treg balance and factors related to autoimmune hepatitis

CD4+ CD25+ but not CD4+ Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis.

An Investigation on Relationship Between the Level of CD4+ CD25+ Regulatory T Cells in the Peripheral Blood and Curative Effect in Patients with Liver Failure

Analysis of the CD4 + CD25 high regulatory T cells in peripheral blood of chronic hepatitis B virus infected patients

Expression Levels of CD4~+CD25~+ Regulatory T Cells in Peripheral Blood of Patients with Chronic Hepatitis B and Clinical Significance

CD4+ T-cell subsets in autoimmune hepatitis: A review

Regulatory Role of CD4 + CD25 + Foxp3 + Regulatory T Cells on IL-17-Secreting T Cells in Chronic Hepatitis B Patients

Significance of the Balance Between Regulatory T (treg) and T Helper 17 (th17) Cells During Hepatitis B Virus Related Liver Fibrosis

The Ratio of Th-17 to Treg Cells is Associated with Survival of Patients with Acute-on-chronic Hepatitis B Liver Failure.

Increased Frequency of CD4+CD25highFoxP3+ Regulatory T Cells in Patients with Hepatocellular Carcinoma

The research of CD4+CD25+Treg and partial cytokines from patients with chronic hepatitis B

Changes of IL-12 and IL-17 Levels in Patients with Autoimmune Liver Disease and Its Clinical Significance

Dysregulated TFR and TFH Cells Correlate with B‐cell Differentiation and Antibody Production in Autoimmune Hepatitis

Research on expression of four important molecules of CD4+CD25+ regulatory T cells In hepatitis B patients